Top Clinical Trials companies in Israel by Price to Earnings Ratio (P/E)

This ranking features the top 5 Clinical Trials companies in Israel ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of -104.07, for January 15, 2025.

Israel

Clinical Trials
Price to Earnings Ratio (P/E)
#
Name
Price to Earnings Ratio (P/E)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
BLRX.TA

BioLineRx Ltd.

1

BLRX.TA

-0.40

 Jan. 14, 2025 USD 0.01 -11.50%

Israel
2
ENLV.TA

Enlivex Therapeutics Ltd.

2

ENLV.TA

-0.88

 Jan. 14, 2025 USD 1.16 -2.88%

Israel
3
CANF.TA

Can-Fite BioPharma Ltd.

3

CANF.TA

-1.32

 Jan. 14, 2025 USD 0.01 0.04%

Israel
4
CGEN.TA

Compugen Ltd.

4

CGEN.TA

-9.93

 Jan. 14, 2025 USD 1.85 10.75%

Israel
5
PPBT.TA

Purple Biotech Ltd.

5

PPBT.TA

-507.82

 Jan. 14, 2025 USD 0.02 -1.36%

Israel
Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest Price to Earnings Ratio (P/E) ?

    The Clinical Trials company in Israel with the highest Price to Earnings Ratio (P/E) is BioLineRx Ltd. (Tel Aviv Stock Exchange: BLRX.TA) at -0.40.

  • Which Clinical Trials company in Israel has the lowest Price to Earnings Ratio (P/E) ?

    The Clinical Trials company in Israel with the lowest Price to Earnings Ratio (P/E) is Purple Biotech Ltd. (Tel Aviv Stock Exchange: PPBT.TA) at -507.82.